Participants | |
n=56 | |
Role in relation to guidelines | |
Guideline developers | 35 |
Researchers | 16 |
Patient and public representatives | 5 |
Country (n=14) | |
Australia | 3 |
Belgium | 2 |
Canada | 5 |
Czech Republic | 3 |
Finland | 5 |
France | 6 |
Germany | 3 |
Japan | 4 |
The Netherlands | 8 |
New Zealand | 2 |
Norway | 5 |
Spain | 4 |
UK | 3 |
USA | 3 |